Literature DB >> 15315177

Nitric oxide formation contributes to beta-adrenergic dilation of epicardial coronary arteries in response to intravenous administration of dobutamine in dogs.

Haoyi Yang1, Youbin Deng, Xiaojun Bi, Qing Chang, Jiao Bai, Min Pan, Huijuan Xiang, Hongyun Liu, Xiulan Li, Yani Liu, Chunlei Li.   

Abstract

To examine the role of nitric oxide in the beta-adrenergic vasodilation of epicardial coronary arteries in dogs, 12 dogs were instrumented for measurement of left anterior descending coronary artery diameter by transthoracic echocardiography before and after dobutamine (5 microg/kg/min IV) with and without intracoronary infusion of NG-monomethyl-L-arginine (L-NMMA) (1 mg/kg). In all 12 dogs, the diameter of left anterior descending coronary artery increased significantly from 2.35 +/- 0.25 mm to 2.59 +/- 0.24 mm (P<0.001) after dobutamine administration. In 6 of the 12 dogs, the percent change in left anterior descending coronary artery diameter induced by dobutamine decreased significantly from 12.5% +/- 8.6% to -1.5% +/- 5.4% (P<0.05) after the administration of intracoronary L-NMMA (1 mg/kg for 5 min) to block nitric oxide synthesis from L-arginine. The study demonstrated that nitric oxide formation contributes to the beta-adrenergic dilatory response of epicardial coronary arteries to dobutamine in dogs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315177     DOI: 10.1007/bf02885426

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  13 in total

1.  A new noninvasive method for evaluation of coronary endothelial function in hypertensive patients based on change in diameter of the left main coronary artery induced by cold pressor test using echocardiography.

Authors:  Y B Deng; X F Wang; C L Li
Journal:  Clin Cardiol       Date:  2001-04       Impact factor: 2.882

Review 2.  Regulatory functions of the vascular endothelium.

Authors:  J R Vane; E E Anggård; R M Botting
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

Review 3.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

4.  Endothelial modulation of beta-adrenergic dilation of large coronary arteries in conscious dogs.

Authors:  B Ghaleh; M L Béa; J L Dubois-Randé; J F Giudicelli; L Hittinger; A Berdeaux
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

5.  Lack of importance of NO in beta-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries.

Authors:  M L Béa; B Ghaleh; J F Giudicelli; A Berdeaux
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

6.  Beta adrenoceptor subtype in isolated human, monkey and dog epicardial coronary arteries.

Authors:  N Toda; T Okamura
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

7.  Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog.

Authors:  S F Vatner; T H Hintze; P Macho
Journal:  Circ Res       Date:  1982-07       Impact factor: 17.367

8.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

9.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

10.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.

Authors:  R M Palmer; D D Rees; D S Ashton; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.